Skip to main content
. 2021 Jun 2;8:658747. doi: 10.3389/fmed.2021.658747

Figure 2.

Figure 2

K-M curve and parametric survival distributions for PFS. PFS, progression-free survival; ABE, abemaciclib; RIB, ribociclib; PAL, palbociclib; FUL, fulvestrant.